Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B)
Meiko Nishimura, Takahiro Kogawa, Keiji Sugiyama, Yukinori Ozaki, Yuko Tanabe, Chikako Funasaka et al. Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B). // Breast Cancer Research and Treatment. – 2026. – DOI: 10.1007/s10549-026-08031-2. – URL: https://doi.org/10.1007/s10549-026-08031-2
Meiko Nishimura, Takahiro Kogawa, Keiji Sugiyama, Yukinori Ozaki, Yuko Tanabe, Chikako Funasaka, Sasagu Kurozumi, Akiyo Yoshimura, Tsutomu Iwasa, Hitomi Sakai, Mitsunori Morita, Satomi Watanabe, Takaaki Fujii, Mitsugu Yamamoto, Yasushi Tsuji, Mitsuo Terada, Takayo Ota, Shinya Tokunaga, Mototsugu Shimokawa, & Toshimi Takano (2026). Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B). Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-026-08031-2
Meiko Nishimura, et al. “Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B).” Breast Cancer Research and Treatment, 2026. doi:10.1007/s10549-026-08031-2.
@article{Nishimura2026,
title = {Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B)},
author = {Nishimura, Meiko and Kogawa, Takahiro and Sugiyama, Keiji and Ozaki, Yukinori and Tanabe, Yuko and Funasaka, Chikako and Kurozumi, Sasagu and Yoshimura, Akiyo and Iwasa, Tsutomu and Sakai, Hitomi and Morita, Mitsunori and Watanabe, Satomi and Fujii, Takaaki and Yamamoto, Mitsugu and Tsuji, Yasushi and Terada, Mitsuo and Ota, Takayo and Tokunaga, Shinya and Shimokawa, Mototsugu and Takano, Toshimi},
journal = {Breast Cancer Research and Treatment},
year = {2026},
doi = {10.1007/s10549-026-08031-2},
url = {https://doi.org/10.1007/s10549-026-08031-2}
}